SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-067361
Filing Date
2011-03-15
Accepted
2011-03-15 17:24:43
Documents
10
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1678143
2 FORM OF OPTION AGREEMENT dex1025.htm EX-10.25 13244
3 DEVELOPMENT AGREEMENT dex1028.htm EX-10.28 105551
4 MASTER SERVICES AGREEMENT dex1029.htm EX-10.29 49004
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 2597
6 CERTIFICATION PURSUANT TO RULE 13A-14(A) OF JOSEPH K. BELANOFF, M.D dex311.htm EX-31.1 9381
7 CERTIFICATION PURSUANT TO RULE 13A-14(A) OF CAROLINE M. LOEWY dex312.htm EX-31.2 9357
8 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 OF JOSEPH K. BELANOFF, M.D. dex321.htm EX-32.1 3862
9 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 OF CAROLINE M. LOEWY dex322.htm EX-32.2 3833
10 GRAPHIC g159565g24m47.jpg GRAPHIC 43025
  Complete submission text file 0001193125-11-067361.txt   1935386
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50679 | Film No.: 11689528
SIC: 2834 Pharmaceutical Preparations